@article{2d6bf4554dca401a9fb4741f4e55126c,
title = "The advantages of switch to subcutaneous bortezomib in the real life",
keywords = "Administration, Intravenous, Antineoplastic Agents/administration & dosage, Bortezomib/administration & dosage, Humans, Injections, Subcutaneous, Multiple Myeloma/diagnosis, Patient Compliance, Patient Satisfaction, Treatment Outcome",
author = "Silvia Mangiacavalli and Federica Cocito and Ferretti, {Virginia Valeria} and Maya Ganzetti and Cartia, {Claudio Salvatore} and Alessandro Corso",
year = "2018",
month = jun,
doi = "10.1080/10428194.2017.1382695",
language = "English",
volume = "59",
pages = "1505--1507",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "6",
}